BioCardia (BCDA) Free Cash Flow (2010 - 2026)

BioCardia (BCDA) has reported Free Cash Flow for 16 consecutive years, with -$1.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Free Cash Flow fell 5.15% year-over-year to -$1.7 million in Q2 2026; TTM through Jun 2026 was -$7.6 million, a 8.94% increase from a year earlier, with the FY2025 full-year figure at -$7.4 million, up 5.69% from the prior year.
• Free Cash Flow was -$1.7 million for Q2 2026 at BioCardia, down from -$1.7 million in the prior quarter.
• Over five years, Free Cash Flow peaked at -$1.3 million in Q2 2024 and troughed at -$3.2 million in Q2 2023.
• A 5-year average of -$2.2 million and a median of -$2.2 million in 2022 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow tumbled 54.03% in 2022 and surged 58.29% in 2024, its largest moves.
• Over 5 years, Free Cash Flow stood at -$3.0 million in 2022, then jumped by 38.28% to -$1.9 million in 2023, then slumped by 31.5% to -$2.4 million in 2024, then declined by 2.83% to -$2.5 million in 2025, then soared by 30.68% to -$1.7 million in 2026.
• The last three Free Cash Flow figures came in at -$1.7 million (Q2 2026), -$1.7 million (Q1 2026), and -$2.5 million (Q4 2025), per Business Quant data.